Speaker illustration

Doctor Ryoko Fujita

Hirakata Kohsai Hospital, Hirakata (Japan)

Prognostic value of polypharmacy in patients with heart failure

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure - Clinical mixed

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb